• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

First experiences with the use of rivaroxaban in the treatment of heparin-induced thrombocytopenia.

作者信息

Ng H J, Than H, Teo E C Y

机构信息

Department of Haematology, Singapore General Hospital, 20 College Road, Singapore 169856, Republic of Singapore.

Department of Haematology, Singapore General Hospital, 20 College Road, Singapore 169856, Republic of Singapore.

出版信息

Thromb Res. 2015 Jan;135(1):205-7. doi: 10.1016/j.thromres.2014.06.005. Epub 2014 Jun 14.

DOI:10.1016/j.thromres.2014.06.005
PMID:24974053
Abstract
摘要

相似文献

1
First experiences with the use of rivaroxaban in the treatment of heparin-induced thrombocytopenia.利伐沙班用于治疗肝素诱导的血小板减少症的初步经验。
Thromb Res. 2015 Jan;135(1):205-7. doi: 10.1016/j.thromres.2014.06.005. Epub 2014 Jun 14.
2
Rivaroxaban for treatment of HIT: a riveting first experience.利伐沙班用于治疗肝素诱导的血小板减少症：一次引人入胜的首次经历。
Thromb Res. 2015 Jan;135(1):1-2. doi: 10.1016/j.thromres.2014.10.019. Epub 2014 Nov 1.
3
Rivaroxaban for treatment of heparin-induced thrombocytopenia after cardiac surgery: A case report.利伐沙班治疗心脏手术后肝素诱导的血小板减少症：一例报告
J Thorac Cardiovasc Surg. 2015 Aug;150(2):e19-20. doi: 10.1016/j.jtcvs.2015.04.054. Epub 2015 May 8.
4
Rivaroxaban for arterial thrombosis related to heparin-induced thrombocytopenia.利伐沙班用于肝素诱导的血小板减少症相关的动脉血栓形成。
Blood Coagul Fibrinolysis. 2015 Mar;26(2):205-6. doi: 10.1097/MBC.0000000000000205.
5
Design of the rivaroxaban for heparin-induced thrombocytopenia study.利伐沙班用于肝素诱导的血小板减少症研究的设计。
J Thromb Thrombolysis. 2014 Nov;38(4):485-92. doi: 10.1007/s11239-014-1064-7.
6
Another off-label novel oral anticoagulant to HIT cardiac surgery patients.另一种用于心脏手术并发肝素诱导的血小板减少症（HIT）患者的非标签新型口服抗凝剂。
J Thorac Cardiovasc Surg. 2015 Aug;150(2):e20-2. doi: 10.1016/j.jtcvs.2015.05.024. Epub 2015 May 12.
7
[Treatment of heparin-induced thrombocytopenia with rivaroxaban. Case report].[利伐沙班治疗肝素诱导的血小板减少症。病例报告]
Rev Med Chil. 2017 Sep;145(9):1213-1217. doi: 10.4067/s0034-98872017000901213.
8
Heparin-induced Thrombocytopenia Presenting With Deep Venous Thrombosis and Pulmonary Embolism Successfully Treated With Rivaroxaban: Clinical Case Report and Review of Current Experiences.利伐沙班成功治疗肝素诱导的血小板减少症伴深静脉血栓形成和肺栓塞：临床病例报告及当前经验回顾
J Cardiovasc Pharmacol. 2016 Nov;68(5):391-394. doi: 10.1097/FJC.0000000000000421.
9
Rivaroxaban for heparin-induced thrombocytopenia: adding to the evidence.利伐沙班用于肝素诱导的血小板减少症：补充证据
Ann Hematol. 2017 Mar;96(3):525-527. doi: 10.1007/s00277-016-2871-z. Epub 2016 Nov 7.
10
Rivaroxaban in treatment refractory heparin-induced thrombocytopenia.利伐沙班治疗难治性肝素诱导的血小板减少症。
BMJ Case Rep. 2016 Aug 12;2016:bcr2016216110. doi: 10.1136/bcr-2016-216110.

引用本文的文献

1
Management of Heparin-Induced Thrombocytopenia: A Contemporary Review.肝素诱导的血小板减少症的管理：当代综述
J Clin Med. 2024 Aug 9;13(16):4686. doi: 10.3390/jcm13164686.
2
Treatment of drug-induced immune thrombocytopenias.药物诱导性免疫性血小板减少症的治疗。
Haematologica. 2022 Jun 1;107(6):1264-1277. doi: 10.3324/haematol.2021.279484.
3
Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses.肝素诱导的血小板减少症的管理：系统评价与荟萃分析
Blood Adv. 2020 Oct 27;4(20):5184-5193. doi: 10.1182/bloodadvances.2020002963.
4
Rivaroxaban Treatment for Heparin-Induced Thrombocytopenia: A Case Report and a Review of the Current Experience.利伐沙班治疗肝素诱导的血小板减少症：一例病例报告及当前经验综述。
Case Rep Hematol. 2020 Sep 3;2020:8885256. doi: 10.1155/2020/8885256. eCollection 2020.
5
Autoimmune Heparin-Induced Thrombocytopenia: Treatment Obstacles and Challenging Length of Stay.自身免疫性肝素诱导的血小板减少症：治疗障碍与住院时间挑战
Am J Case Rep. 2019 Mar 9;20:310-313. doi: 10.12659/AJCR.914575.
6
Drug-associated thrombocytopenia.药物相关性血小板减少症。
Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):576-583. doi: 10.1182/asheducation-2018.1.576.
7
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.美国血液学会 2018 年静脉血栓栓塞症管理指南：肝素诱导的血小板减少症。
Blood Adv. 2018 Nov 27;2(22):3360-3392. doi: 10.1182/bloodadvances.2018024489.
8
Emerging Role of Direct Oral Anticoagulants in the Management of Heparin-Induced Thrombocytopenia.直接口服抗凝剂在肝素诱导的血小板减少症管理中的新作用。
Clin Appl Thromb Hemost. 2018 Mar;24(2):201-209. doi: 10.1177/1076029617696582. Epub 2017 Mar 6.
9
Heparin-induced thrombocytopenia: research and clinical updates.肝素诱导的血小板减少症：研究与临床进展
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):262-268. doi: 10.1182/asheducation-2016.1.262.
10
Direct oral anticoagulants in hypercoagulable states.高凝状态下的直接口服抗凝剂
J Thromb Thrombolysis. 2017 Jan;43(1):79-85. doi: 10.1007/s11239-016-1420-x.